Company Overview
Global Headquarters:
Marlborough, Massachusetts, USA
Ownership: Indirectly, wholly-owned subsidiary of Sumitomo Pharma Co., Ltd.

Core Therapeutic Areas: Address serious psychiatric and neurologic conditions
Global locations:
Sunovion Pharmaceuticals Inc., Fort Lee, New Jersey
Sunovion Pharmaceuticals Canada, Inc., Mississauga, Ontario
Discover Sunovion

Asset Library
Executive Team
Media Inquiries 
For any media inquiries or logo usage requirements,
please contact Sunovion Corporate Communications at 508-357-7740
or email corpcomm@sunovion.com
Connect With Us
Looking for more news from Sunovion? Follow us on social media.